New York Times :: Coronavirus Vaccine Tracker

Milestones :: Perspectives :: Research

 

New York Times :: Coronavirus Vaccine Tracker
14 Jan 2021

 

New additions and recent updates
Jan. 14
The Israel Institute for Biological Research moves to Phase 2.
Jan. 13
Brazil announces Sinovac’s vaccine has an efficacy of just over 50 percent.
Jan. 12
California-based Arcturus moves to Phase 2.
Jan. 12
Canada’s VIDO enters Phase 1/.